Contrary to the previous report we conclude all the transcripts of plasmodium genes have diverse start sites.
2
Plasmodium falciparum causes severe malaria infections in millions of people every year.
3
Age and not schooling were risk factors for Plasmodium and STH co-infection.
4
The key targets of protective antibodies against Plasmodium falciparum remain largely unknown.
5
Plasmodium vivax is the most prevalent human malaria parasite outside of Africa.
1
Plasmodium vivax is the most prevalent human malariaparasite outside of Africa.
2
There was no association between the malariaparasite density and severe anaemia.
3
Individuals who were not exposed to the malariaparasite completely lack anti-GPI antibodies.
4
Gametocytes are the malariaparasite stages responsible for transmission from humans to mosquitoes.
5
Recent years have seen rapid advances in our understanding of malariaparasite cell biology.
Uso de Plasmodium vivax em inglês
1
The prevalence of Plasmodiumvivax infection has been increasing in the past decades.
2
We have recently described a Plasmodiumvivax-like human malaria parasite.
3
People lacking the receptor are protected against infection by a malaria parasite known as Plasmodiumvivax.
4
Most pregnant women at risk of for infection with Plasmodiumvivax live in the Asia-Pacific region.
5
The protozoan Plasmodiumvivax is responsible for 42% of all cases of malaria outside Africa.
6
The widespread distribution and relapsing nature of Plasmodiumvivax infection present major challenges for the elimination of malaria.
7
These data are key to a rational drug policy for malaria elimination of Plasmodium falciparum and Plasmodiumvivax.
8
The gene encoding a cysteine proteinase of the human malaria parasite Plasmodiumvivax has been identified and characterized.
9
This study aimed to provide data on the therapeutic efficacy of CQ against Plasmodiumvivax malaria in southern Ethiopia.
10
Differential diagnosis is particularly important in cases of Plasmodiumvivax, a species that shares endemicity with P. falciparum in most endemic areas.
11
Background: How antimalarial antibodies are acquired and maintained during pregnancy and boosted after reinfection with Plasmodium falciparum and Plasmodiumvivax is unknown.
12
Little is known of the genetic diversity and population structure of Plasmodiumvivax, a debilitating and highly prevalent malaria parasite of humans.
13
No radical treatment with primaquine was provided for Plasmodiumvivax cases, which could explain the slow decrease of P. vivax due to relapses.
14
To determine the magnitude of Plasmodiumvivax relapsing malaria in rural Amazonia, we carried out a study in four sites in northeastern Peru.
15
Background: Plasmodiumvivax is the second most prevalent malaria parasite affecting more than 75 million people each year, mostly in South America and Asia.
16
This study tested the hypothesis that pro- or anti-inflammatory cytokines are associated with transmission of Plasmodiumvivax to Anopheles darlingi mosquitoes in experimental infection.